International Journal of Hematology (2018) 107:392–394 https://doi.org/10.1007/s12185-018-2425-3 PROGRESS IN HEMATOLOGY Current status and progress of lymphoma research in East Asian countries Current status and progress of lymphoma research in East Asian countries: Introduction and planning Junji Suzumiya Received: 14 February 2018 / Accepted: 18 February 2018 / Published online: 28 February 2018 © The Japanese Society of Hematology 2018 Introduction was reported that diffuse large B-cell lymphoma (DLBCL) accounted for 33% of cases, and follicular lymphoma (FL) This issue of International Journal of Hematology presents and adult T-cell leukemia-lymphoma (ATL) accounted for four review articles relating to “Progress in Hematology” 18% and 10% of cases, respectively . In a study of 4638 (PIH). Chinese lymphoma patients conducted between 2004 and Malignant lymphoma (lymphoma) is the most common 2008, DLBCL was the most common subtype of lymphoma, hematological malignancy; however, the term “lymphoma” accounting for 36% of cases, which was similar to its fre- encompasses a heterogenous group of biologically and quency in the Japanese study. Extra-nodal NK-cell lym- clinically distinct neoplasms. Lymphoma originates from phoma, nasal type (ENKL) accounted for 11% of cases , lymphoid cells and is divided into B-cell lymphoma, T/NK which was higher than its frequency in the Japanese
International Journal of Hematology – Springer Journals
Published: Feb 28, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera